3rd Quarter - Report

INTEGRATED SOLUTIONS GROUP for TEVA PHARMACEUTICALS USA

Period 3rd Quarter 2010 Filed Oct 19, 2010 Signed by Keisha L. Jones, Office Administrator

Official filing
Firm
INTEGRATED SOLUTIONS GROUP
Client
TEVA PHARMACEUTICALS USA
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 1432 - Patent Settlements; H.R. 1695 - Generic Biologics; H.R. 5629 - Physician Payment Sunshine Act; S.2029 - Patent Reform; H.R. 1908 - Import Safety Act; H.R. 3100 - Affordable Health Choices Act S.515 - Patent Reform Act Financial services and general appropriations bill - 2010

LobbyistCovered position, as disclosed
MOSES BOYD Counsel, Senate Commerce Committee
MYCHAL S BOYD —
G JOHN O'HANLON —
ADAM S OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 1695 (111th), H.R. 1432 (111th), H.R. 1908 (111th), H.R. 3100 (111th), H.R. 5629 (111th), S. 515 (111th), S. 2029 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.